$101.45
1.691.69%
At Close: -
$101.45
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Ligand Pharmaceuticals
LGNDNASDAQ
Ligand Pharmaceuticals (NASDAQ:LGND) Stock, Earnings Estimates, EPS, And Revenue
Ligand Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 6
EPS Estimate
$0.980
Quarterly Revenue Estimate
$31.9M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$118.3M
Analyze the earnings history of Ligand Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LGND | Ligand Pharmaceuticals | $1.42 | $0.98 | — | — | $26.37M | $31.90M | — | — | 08/06/2024 | Get Alert |
| LGND | Ligand Pharmaceuticals | $2.28 | $0.78 | $3.84 | 392.31% | $43.98M | $27.92M | $30.98M | 10.95% | 05/07/2024 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.36 | $0.66 | $1.38 | 109.09% | $50.38M | $25.72M | $28.10M | 9.26% | 02/27/2024 | Get Alert |
| LGND | Ligand Pharmaceuticals | $0.60 | $0.61 | $1.02 | 67.21% | $59.22M | $27.19M | $32.87M | 20.88% | 11/08/2023 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.03 | $0.64 | $1.42 | 121.88% | $57.42M | $25.73M | $26.37M | 2.47% | 08/08/2023 | Get Alert |
| LGND | Ligand Pharmaceuticals | $0.76 | $0.89 | $2.28 | 156.18% | $45.69M | $34.04M | $43.98M | 29.20% | 05/04/2023 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.80 | $1.19 | $1.36 | 14.29% | $72.47M | $46.64M | $50.38M | 8.02% | 02/22/2023 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.58 | $0.43 | $1.31 | 204.65% | $64.83M | $38.28M | $66.09M | 72.64% | 11/07/2022 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.63 | $0.43 | $1.03 | 139.53% | $84.67M | $37.73M | $57.42M | 52.18% | 08/08/2022 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.41 | $0.66 | $0.76 | 15.15% | $55.15M | $34.21M | $45.69M | 33.57% | 05/04/2022 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.62 | $1.37 | $1.80 | 31.39% | $69.99M | $65.32M | $72.47M | 10.95% | 02/17/2022 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.04 | $1.04 | $1.58 | 51.92% | $41.85M | $55.65M | $64.83M | 16.50% | 11/09/2021 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.00 | $1.34 | $1.63 | 21.64% | $41.42M | $70.41M | $84.67M | 20.26% | 07/29/2021 | Get Alert |
| LGND | Ligand Pharmaceuticals | $0.89 | $1.12 | $1.41 | 25.89% | $33.16M | $62.85M | $55.15M | -12.25% | 05/03/2021 | Get Alert |
| LGND | Ligand Pharmaceuticals | $0.71 | $0.99 | $1.62 | 63.64% | $27.00M | $54.09M | $69.99M | 29.40% | 02/03/2021 | Get Alert |
| LGND | Ligand Pharmaceuticals | $0.49 | $0.98 | $1.04 | 6.12% | $24.81M | $44.36M | $41.85M | -5.66% | 10/30/2020 | Get Alert |
| LGND | Ligand Pharmaceuticals | $0.68 | $0.76 | $1.00 | 31.58% | $24.99M | $29.96M | $41.42M | 38.25% | 08/03/2020 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.16 | $0.66 | $0.89 | 34.85% | $43.48M | $26.53M | $33.16M | 24.99% | 05/06/2020 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.70 | $0.61 | $0.71 | 16.39% | $59.59M | $25.16M | $27.00M | 7.33% | 02/06/2020 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.32 | $0.61 | $0.49 | -19.67% | $45.66M | $22.36M | $24.81M | 10.95% | 11/05/2019 | Get Alert |
| LGND | Ligand Pharmaceuticals | $2.59 | $0.55 | $0.68 | 23.64% | $90.04M | $21.01M | $24.99M | 18.93% | 07/30/2019 | Get Alert |
Ligand Pharmaceuticals (LGND) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-07 | $3.84 | $0.78 | 392.3 % |
| Dec 2023 | 2024-02-27 | $1.38 | $0.66 | 109.1 % |
| Sep 2023 | 2023-11-08 | $1.02 | $0.61 | 67.2 % |
| Jun 2023 | 2023-08-08 | $1.42 | $0.64 | 121.9 % |
Ligand Pharmaceuticals (LGND) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-07 | $30.98M | $27.92M | 10.9 % |
| Dec 2023 | 2024-02-27 | $28.10M | $25.72M | 9.26 % |
| Sep 2023 | 2023-11-08 | $32.87M | $27.19M | 20.9 % |
| Jun 2023 | 2023-08-08 | $26.37M | $25.73M | 2.47 % |
FAQ
When is Ligand Pharmaceuticals (NASDAQ:LGND) reporting earnings?
Ligand Pharmaceuticals (LGND) is scheduled to report earnings on August 6, 2024. The last reported earnings were for reported on May 7, 2024 for Q1.
What were the latest earnings per share (EPS) for Ligand Pharmaceuticals (NASDAQ:LGND)?
The Actual EPS was $3.84, which beat the estimate of $0.78.
What were Ligand Pharmaceuticals’s (NASDAQ:LGND) revenues?
The Actual Revenue was $31M, which beat the estimate of $27.9M.
Browse earnings estimates, EPS, and revenue on all stocks.